Organization
AP-HM Hospital
4 abstracts
Abstract
Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma: Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study.Org: Istituto Nazionale Tumori IRCCS Fondazione Pascale, Hospital Universitario Virgen Macarena, Maria Skłodowska-Curie National Institute of Oncology Center, Poznan University of Medical Sciences and Greater Poland Cancer Center, UPMC Hillman Cancer Center,
Abstract
Recurrent genetic alterations in primary central nervous system lymphoma of immunocompetent patients.Org: APHP-INSERM U1149 Universite Paris Diderot, UPMC Health Plan, CRICM, UMR975, UMR U975,
Abstract
Clinical benefit of personalized treatment following high throughput sequencing in metastatic melanoma: A national retrospective study.Org: Dermatology and Skin Cancer Department, AP-HM Marseille, Dermatology Departement, Cochin Hospital, APHP,Université Paris Cité, Paris, France, CHU de Bordeaux, Cochin Hospital,
Abstract
ASSOCIATION BETWEEN HLA-DRB1*04:01, RHEUMATOID NODULES AND PARTICULAR EPITOPES OF CITRULLINATED FIBRIN IN PATIENTS WITH RHEUMATOID ARTHRITISOrg: AP-HM Hospital, UDEAR, Centre Hospitalier Universitaire (CHU) de Toulouse, Institut Fédératif de Biologie, Laboratory of Cell Biology and Cytology,